Literature DB >> 407178

Cost/benefit analysis of treatment and prevention of myocardial infarction.

S Cretin.   

Abstract

The benefits resulting from introduction of coronary care units, mobile coronary care units, and a screening and intervention program to decrease the incidence of myocardial infarction (MI) are reduced to a common basis by modeling the effects of the three strategies as applied to a cohort of 10-years-olds. Published data on MI are used with a semi-Markov model of death from MI and other causes to estimate program effects on long-term survival, and cost/benefit ratios are compared for the three programs with both costs and benefits discounted over the lifetime of the cohort. Some problems of selecting a discount rate for comparing programs that incur costs and accrue benefits at widely separated times are discussed.

Entities:  

Mesh:

Year:  1977        PMID: 407178      PMCID: PMC1071979     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  14 in total

1.  CORONARY UNIT: AN INTENSIVE-CARE CENTRE FOR ACUTE MYOCARDIAL INFARCTION.

Authors:  K W BROWN; R L MACMILLAN; N FORBATH; F MELGRANO; J W SCOTT
Journal:  Lancet       Date:  1963-08-17       Impact factor: 79.321

2.  150 Patients with cardiac infarction treated in a coronary unit.

Authors:  N Restieaux; C Bray; H Bullard; M Murray; J Robinson; W Brigden; L McDonald
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

3.  Normal serum cholesterol values. Percentile ranking in a middle-class pediatric population.

Authors:  G Friedman; S J Goldberg
Journal:  JAMA       Date:  1973-08-06       Impact factor: 56.272

4.  A community program for emergency cardiac care. A three-year coronary ambulance-paramedic evaluation.

Authors:  W S Graf; S S Polin; B L Paegel
Journal:  JAMA       Date:  1973-10-08       Impact factor: 56.272

5.  Prehospital ventricular defibrillation. Prognosis and follow-up course.

Authors:  R R Liberthson; E L Nagel; J C Hirschman; S R Nussenfeld
Journal:  N Engl J Med       Date:  1974-08-15       Impact factor: 91.245

6.  Symposium on arteriosclerotic heart disease. The prehospital phase of treatment for myocardial infarction.

Authors:  A A Adgey; J F Pantridge
Journal:  Geriatrics       Date:  1972-05

7.  The coronary care unit and mortality from myocardial infarction: a continued evaluation.

Authors:  I D Fagin; K M Anandiah
Journal:  J Am Geriatr Soc       Date:  1971-08       Impact factor: 5.562

8.  Survival in acute myocardial infarction before and after the establishment of a coronary care unit.

Authors:  D K Bloomfield; J Slivka; S Vossler; J Edelstein
Journal:  Chest       Date:  1970-03       Impact factor: 9.410

9.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

Authors:  J L Goldstein; H G Schrott; W R Hazzard; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

10.  Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women.

Authors:  M Miettinen; O Turpeinen; M J Karvonen; R Elosuo; E Paavilainen
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

View more
  3 in total

Review 1.  The generation gap: differences between children and adults pertinent to economic evaluations of health interventions.

Authors:  Ron Keren; Susmita Pati; Chris Feudtner
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis.

Authors:  N S Hartunian; C N Smart; M S Thompson
Journal:  Am J Public Health       Date:  1980-12       Impact factor: 9.308

3.  Discounting surgical benefits. Enucleation versus resection of the prostate.

Authors:  R Woodward; S Boyarsky; H Barnett
Journal:  J Med Syst       Date:  1983-12       Impact factor: 4.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.